Health Secretary Matt Hancock says he will not rule out ‘compulsory vaccination’
May 7, 2019Manufacturing and Production, Sales and Marketing Matt Hancock, infectious diseases, pharma, public health, vaccines
Health Secretary Matt Hancock has said he would not rule out ‘compulsory vaccination,’ as he argued that those spreading anti-vaccine …
GSK and Innoviva’s triple asthma therapy Trelegy Ellipta impresses at Phase 3
May 3, 2019Medical Communications, Research and Development GSK, Innoviva, Trelegy, ellipta, pharma
GSK and partner Innoviva have lifted the curtain on new Phase 3 data for their single inhaler triple therapy Trelegy …
ABPI names Novartis’ Haseeb Ahmad as new President
May 3, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Novartis, appointment, pharma
The Association of the British Pharmaceutical Industry (ABPI) has revealed the appointment of a new President: Haseeb Ahmad will assume …
Top Ten most popular articles on Pharmafile.com this week!
May 3, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Gilead, autism, dementia, opioids, pharma
This week was marked by the failure of two Phase 3 trials after both Eli Lilly and Gilead suffered from …
Insys Therapeutics founder John Kapoor found guilty of bribing doctors
May 3, 2019Medical Communications Insys Therapeutics, John Kapoor, Subsys, fentanyl, opioid crisis, opioids, pharma
The founder of opioid drugmaker Insys Therapeutics has been found guilty of bribing doctors in order to persuade them to …
HIV cannot be transmitted when viral load is undetectable, study shows
May 3, 2019Medical Communications Art, HIV, U=U, anti-retroviral drugs, infectious diseases, pharma
The risk of transmitting HIV through gay sex when the infected partner’s HIV load has been fully supressed by antiretroviral …
Sanofi’s Dengvaxia becomes first FDA-approved dengue vaccine, but with caveats…
May 2, 2019Sales and Marketing FDA, Sanofi, dengue, dengvaxia, pharma
Sanofi has announced that the FDA has granted authorisation to its tetravalent vaccine Dengvaxia for prevention of dengue disease originating …
Allergan shareholders reject proposal to split roles of chairman and CEO
May 2, 2019Research and Development Allergan, Appaloosa, CEO, board of directors, hedge fund, pharma
Allergan shareholders have rejected a proposal to immediately separate the roles of CEO and chairman, both of which are currently …
Takeda opens R&D facility in San Diego, California
May 2, 2019Manufacturing and Production, Research and Development CNS, GI, Japan, Takeda, california, neuroscience, san diego
Japanese-firm Takeda pharmaceuticals has opened a new research facility in San Diego, California. The 165,000ft2 research centre will employ 250 …
Hormone-based therapies show promise in children and adults with autism
May 2, 2019Research and Development ASD, autism, pharma, vasopressin
A hormone-based therapy might improve social function in people with autism, according to the results of two separate clinical trials. …
Ambien and other insomnia meds to be labelled with black box warnings after sleepwalking deaths
May 2, 2019Medical Communications, Research and Development FDA, ambien, black box warning, insomnia, sleeping pills, warning label
The FDA has said that Ambien, and other insomnia medications, must be labelled with a ‘black box warning’ – the …
FDA approves AbbVie’s Mavyret for children with Hepatitis C (HCV)
May 1, 2019Research and Development AbbVie, HCV, hepatitis C, mavyret, pharma
The FDA has approved AbbVie’s Mavyret tables (glecaprevir/pibrentasvir) as a treatment for hepatitis C (HCV) in children aged 12 to 17 …
FDA refuses to review Nabriva’s injectable antibiotic for urinary tract infections
May 1, 2019Research and Development, Sales and Marketing Contepo, Nabriva, pharma, urinary tract infections
Biopharma firm Nabriva Therapeutics has revealed that its antibiotic Contepo (fosfomycin) has been rejected for review by the FDA as …
Diabetes drug may help people quit smoking
May 1, 2019Research and Development UTHealth, clinical trials, diabetes, smoking smoking cessation
A diabetes drug may help people quit smoking, according to researchers at the University of Texas Health Science Center at …
Gilead’s CFO and Executive Vice President to depart in 2020
May 1, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment, pharma
Gilead has announced that Robin Washington, the company’s Senior Vice President and Chief Financial Officer of more than a decade, …
Scientists identify new form of dementia
May 1, 2019Research and Development AD, Alzheimer's, dementia, late, neuroscience
A team of scientists from Britain and the United States have described a new form of dementia, according to a …
GSK’s Benlysta becomes first FDA-approved IV therapy for paediatric lupus
April 30, 2019Manufacturing and Production, Sales and Marketing Benlysta, FDA, GSK, Lupus, US, pharma
GSK has scored approval in the US with Benlysta (belimumab) for the treatment of systemic lupus erythematosus (SLE) in paediatric …
Two thirds of MPs believe NHS should spend less on medicines
April 30, 2019Manufacturing and Production Long Term Plan, MPs, NHS, UK, government, health, public health
Nearly two thirds (64%) of MPs believe the NHS should direct more resources towards prevention, over funding for new treatments, …
Donald Trump says he will not accept campaign money from pharma
April 30, 2019Manufacturing and Production Donald Trump, USA, campaign contributionss, pharma, politics
President Donald Trump has said he will not accept money from pharmaceutical companies in the run up to the 2020 …
New Phase 3 data confirms safety and efficacy of UCB’s Cimzia in plaque and psoriatic arthritis
April 30, 2019Manufacturing and Production, Research and Development Cimzia, UCB Pharma, pharma, plaque psoriasis, psoriasis
New Phase 3 data has been released by UCB Pharma on the safety of Cimzia (certolizumab pegol) in the treatment …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
